Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Alliança Saúde e Participações S.A. functions as a holding entity primarily focused on delivering medical diagnostic services. Its comprehensive service portfolio encompasses diagnostic imaging, record-based assessments, nuclear medicine procedures, cytological analysis, anatomical pathology, and a range of clinical laboratory tests. Geraldo Mol Starling Filho established the organization on August 5, 1992, and its central operations are located in Sao Paulo, Brazil.
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap' on
Target Price
The average target price of AALR3.SA is 2.33 and suggests 28.5% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation